Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pomegranate + ginkgo biloba is an investigational topical anti-aging cream formulation developed by Ahmed A. H. Abdellatif. The product is a vanishing cream (O/W or W/O emulsion) containing extracts of *Punica granatum* (pomegranate) and *Ginkgo biloba* as its primary active ingredients. It is designed to treat skin aging by reducing the depth of deep furrows and wrinkles, such as crow's feet. The formulation is prepared by reacting stearic acid with an alkali to form a soap base before incorporating the botanical extracts. It has been evaluated in a Phase 1 clinical trial (NCT03772418) to assess its efficacy in improving skin quality over a three-month period.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pomegranate + ginkgo biloba.